Related Experiment Videos

Neonatal estrogen exposure alters the transforming growth factor-beta signaling system in the developing rat prostate

W Y Chang1, L Birch, C Woodham

  • 1Department of Urology, University of Illinois College of Medicine, Chicago 60612, USA.

Endocrinology
|May 26, 1999
PubMed

Insights

Neonatal estrogen exposure disrupts transforming growth factor-beta (TGFbeta) signaling in developing rat prostates, impairing epithelial differentiation and promoting abnormal cell growth. This study reveals TGFbeta pathway perturbations contributing to prostate abnormalities after early-life estrogenization.

Area of Science:

  • Developmental biology
  • Endocrinology
  • Prostate cancer research

Background:

  • Neonatal exposure to estrogens in male rats causes prostate developmental abnormalities, including impaired morphogenesis and differentiation.
  • The underlying mechanisms by which neonatal estrogenization affects prostate development remain incompletely understood.
  • Transforming growth factor-beta (TGFbeta) is a critical signaling pathway involved in prostate development and homeostasis.

Purpose of the Study:

  • To investigate the role of TGFbeta signaling in the ventral prostate of rats neonatally exposed to estrogens.
  • To determine if TGFbeta pathway alterations mediate the effects of neonatal estrogenization on prostate development.

Main Methods:

  • Immunocytochemistry was used to localize active TGFbeta1, its latency-associated peptide, and TGFbeta signaling components (receptors, Smad2, p21(cip-1/waf-1)) in rat prostates.
  • Reverse transcription-polymerase chain reaction (RT-PCR) assessed TGFbeta1 transcription levels.
  • Neonatal estrogenization was induced in male rats, and prostates were analyzed at various time points post-exposure.

Main Results:

  • Neonatal estrogenization increased TGFbeta1 accumulation in smooth muscle but not its transcription; TGFbeta2 and TGFbeta3 levels in epithelial cells were reduced.
  • Estrogen exposure transiently decreased TGFbeta type I receptor in prostate epithelium and prevented the normal induction of p21(cip-1/waf-1), a TGFbeta-inducible marker of differentiation.
  • These perturbations in the TGFbeta signaling system occurred alongside epithelial differentiation blockade and periductal fibroblast proliferation.

Conclusions:

  • The TGFbeta signaling system is significantly perturbed at multiple levels in the neonatally estrogenized rat prostate.
  • These disruptions in TGFbeta signaling likely contribute to the observed blockade of epithelial cell differentiation.
  • Altered TGFbeta signaling may also play a role in the proliferation of periductal fibroblasts, leading to prostate abnormalities.

Related Concept Videos